YOLFTbeta
Luyan Pharma Co Ltd

Luyan Pharma Co Ltd

002788 · SHE · Healthcare / Pharmaceutical Retailers

9.32CNY-0.43 (-4.41%)

Price History

Full chart

Market Stats

Previous Close9.75
Open9.75
Day Range9.30 – 9.75
52-Week Range7.72 – 27.31
Volume13.10M
Market Cap4.18B
P/E (TTM)15.59
Forward P/E0.00
EPS0.69
Dividend Yield3.25%
Beta0.00
50-Day Avg10.87
200-Day Avg13.95

About

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Jinxiang Wu
  • Employees5.72K
  • HeadquartersNo. 1004, Anling Road, Xiamen, China, 361015, China
  • Websitehttps://www.luyan.com.cn

Leadership

  • Mr. Jinxiang WuChairman & GM · b. 1962
  • Mr. Di WuDeputy GM & Vice Chairman · b. 1991
  • Ms. Zheng ZengChief Financial Officer · b. 1986
  • Mr. Lei MingDeputy GM, Chief Compliance Officer & Director · b. 1975
  • Mr. Quanqing YeSecretary · b. 1977
  • Mr. Ming Guo ZhuDeputy GM & Vice President · b. 1969
  • Mr. Wei Yang LiDeputy General Manager · b. 1970
  • Ms. Jun Ying ZhangDeputy General Manager · b. 1972
  • Mr. Jin LiuDeputy General Manager · b. 1975

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.95B4.69B5.52B6.30B6.63B6.98B8.34B11.50B15.01B15.54B17.55B19.46B19.85B20.47B21.25B
Growth (%)-+58.97%+17.76%+14.13%+5.17%+5.39%+19.41%+37.93%+30.50%+3.51%+12.94%+10.93%+1.97%+3.15%+3.79%
Cost of Revenue2.71B4.33B5.05B5.77B6.10B6.46B7.69B10.61B13.85B14.31B16.18B17.95B18.34B18.95B19.74B
Gross Profit234.07M358.91M469.27M532.58M525.92M525.65M644.08M891.82M1.16B1.23B1.37B1.51B1.51B1.52B1.50B
Gross Margin7.94%7.66%8.50%8.45%7.94%7.53%7.72%7.75%7.75%7.90%7.79%7.77%7.59%7.44%7.08%
Operating Expense148.55M194.22M323.75M386.40M373.69M371.52M445.42M630.89M816.66M853.30M960.14M1.05B1.04B1.06B906.20M
Operating Income85.52M164.70M145.52M146.18M152.23M154.12M198.66M260.94M346.13M373.77M405.88M465.94M468.56M458.10M597.30M
Operating Margin2.90%3.51%2.64%2.32%2.30%2.21%2.38%2.27%2.31%2.41%2.31%2.39%2.36%2.24%2.81%
EBITDA109.44M130.96M225.38M258.01M267.76M246.61M305.23M419.58M535.90M594.09M666.22M745.48M756.29M734.39M694.36M
EBITDA Margin3.71%2.79%4.08%4.10%4.04%3.53%3.66%3.65%3.57%3.82%3.80%3.83%3.81%3.59%3.27%
Net Income63.62M90.51M108.28M109.33M113.48M115.52M130.58M180.32M255.89M266.63M305.87M345.16M363.53M345.64M280.88M
Net Income Margin2.16%1.93%1.96%1.74%1.71%1.65%1.57%1.57%1.70%1.72%1.74%1.77%1.83%1.69%1.32%
R&D----623.16K623.16K628.04K2.64M5.19M3.86M2.97M4.15M5.53M5.85M6.52M
R&D as % of Total Revenue----0.01%0.01%0.01%0.02%0.03%0.02%0.02%0.02%0.03%0.03%0.03%
Interest Expense16.08M067.31M88.64M91.72M67.61M79.21M124.99M149.71M174.47M196.52M224.02M228.02M214.52M178.36M
Interest Expense % of Total Revenue0.55%0.00%1.22%1.41%1.38%0.97%0.95%1.09%1.00%1.12%1.12%1.15%1.15%1.05%0.84%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.33B2.22B2.83B3.31B3.43B3.51B5.13B6.07B7.54B8.43B9.99B11.78B11.79B12.64B13.40B
Total Liabilities973.17M1.78B2.27B2.66B2.68B2.13B3.57B4.42B5.65B6.03B7.43B8.99B8.82B9.45B10.07B
Total Equity354.04M445.70M553.80M642.27M737.57M1.37B1.47B1.57B1.79B2.34B2.49B2.72B2.95B3.16B3.31B
Cash170.69M282.92M355.95M579.71M470.25M424.70M541.81M516.72M428.94M595.37M415.43M594.19M606.30M576.85M616.96M
Total Debt272.20M546.26M923.50M1.13B1.16B917.02M1.79B2.27B3.25B3.48B4.47B5.06B4.64B4.61B-
Net Debt101.51M263.34M567.55M548.28M685.98M492.31M1.25B1.75B2.82B2.89B4.06B4.47B4.04B4.03B3.80B

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow28.01M-32.94M-76.47M177.89M219.31K-128.03M-447.16M126.77M-629.14M77.22M-372.02M232.19M1.31B577.48M688.40M
Investing Cash Flow-42.39M-91.49M-170.38M-71.24M-42.45M-99.19M-285.52M-392.46M-225.96M-178.60M-273.36M-329.16M-534.24M-369.73M-
Financing Cash Flow51.99M241.57M306.05M116.88M-67.64M180.25M770.75M205.46M747.60M295.93M475.68M184.46M-708.99M-328.56M-
Capital Expenditure34.05M85.52M137.50M85.14M42.28M110.16M84.23M133.88M198.90M170.62M243.49M327.58M529.21M361.12M233.74M
Free Cash Flow-6.05M-118.46M-213.96M92.75M-42.06M-238.19M-531.40M-7.11M-828.04M-93.40M-615.51M-95.40M779.91M216.36M454.66M
Dividends Paid40.08M37.49M58.05M93.85M94.70M91.54M98.30M177.02M38.45M49.02M98.90M116.56M340.10M323.83M313.96M
FCF to OCF-21.59%359.59%279.81%52.14%-19179.71%186.04%118.84%-5.61%131.61%-120.95%165.45%-41.09%59.58%37.47%66.05%
Dividend Paid to FCF-662.84%-31.65%-27.13%101.19%-225.13%-38.43%-18.50%-2488.58%-4.64%-52.49%-16.07%-122.18%43.61%149.67%69.05%

Earnings

Report DateApr 25, 2016Jul 21, 2016Oct 24, 2016Feb 20, 2017Apr 17, 2017Aug 7, 2017Oct 23, 2017Feb 26, 2018Apr 24, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Oct 23, 2019Dec 31, 2019Apr 30, 2020Aug 11, 2020Oct 26, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Oct 23, 2023Dec 31, 2023May 7, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 7, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------0.22---0.28-----------0.24-----------
EPS Actual0.060.090.070.110.070.110.090.100.090.140.160.130.130.220.230.170.160.240.240.140.170.230.190.200.180.250.210.240.210.280.190.260.220.270.170.230.180.210.170.160.170.19
Surprise--------------4.55%----14.29%------------20.83%-----------
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market-----Pre-market---Pre-market-----------Pre-market-After-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.18B
Enterprise Value8.83B
Trailing P/E15.59
Forward P/E0.00
Price / Sales0.20
Price / Book1.27
EPS0.69
Book Value8.53
Revenue (TTM)21.43B
Gross Profit (TTM)1.48B
EBITDA629.01M
Profit Margin1.26%
Operating Margin2.66%
Return on Equity8.12%
Return on Assets2.66%
Shares Outstanding388.52M
Shares Float232.28M
Beta0.00
Dividend Yield3.25%
Dividend Rate0.35
Payout Ratio50.48%

Dividends

20261×
0.35Jul 10, 2026
20251×
0.35Jul 10, 2025
20241×
0.30Jul 4, 2024
20231×
0.30Jun 14, 2023
20221×
0.30Jul 6, 2022
20211×
0.20Jun 3, 2021
20201×
0.14Jun 8, 2020
20191×
0.11May 29, 2019
20181×
0.07May 25, 2018
20171×
0.07Jun 7, 2017
20161×
0.07Jun 16, 2016

Stock Splits

  • May 29, 20191.7:1
  • May 25, 20181.5:1